P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1

Detalles Bibliográficos
Autores principales: van de Donk, Niels W.C.J., Garfall, Alfred, Benboubker, Lotfi, Uttervall, Katarina, Groen, Kaz, Rosiñol Dachs, Laura, Hodin, Caroline, Stephenson, Tara, Trancucci, Danielle, Perales-Puchalt, Alfredo, Kobos, Rachel, Banerjee, Arnob, Mateos, Maria-Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431116/
http://dx.doi.org/10.1097/01.HS9.0000970548.43149.cb

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431116/
http://dx.doi.org/10.1097/01.HS9.0000970548.43149.cb

Ejemplares similares